{"id":"W2108278478","doi":"10.3899/jrheum.120886","title":"Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study","year":2013,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Belimumab; Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Rheumatology; Clinical endpoint; Adverse effect; Randomized controlled trial; Gastroenterology; Immunology; B-cell activating factor; Antibody; Pathology; B cell","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003325603,0.001282893,0.002916406,0.0004547128,0.0005476361,0.0007895022,0.0008264285,0.001554737,0.003590314],"category_scores_gemma":[0.001929789,0.0007829455,0.001242704,0.0004590748,0.001222005,0.00113439,0.0003640717,0.002581393,0.0008525045],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004984603,"about_ca_system_score_gemma":0.001141795,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002915282,"about_ca_topic_score_gemma":0.0005709502,"domain_scores_codex":[0.9989234,0.0005619043,0.0001058235,0.0001581685,0.00012801,0.0001226686],"domain_scores_gemma":[0.9985921,0.0003806421,0.000353005,0.0001035396,0.000117185,0.0004535705],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9334438,0.02408078,0.001492196,0.000628364,0.0007052392,0.00006303665,0.00008833015,0.0003183805,0.01169744,0.00006611567,0.0005319768,0.02688439],"study_design_scores_gemma":[0.8523364,0.1434489,0.002387075,0.00001889481,0.0002471377,0.00005482039,0.00001489709,0.0002898989,0.0006976843,0.00004370642,0.000449006,0.00001150852],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9893802,0.004345957,0.001012242,0.0004822246,0.0002433221,0.00306192,0.0004953075,0.0001143526,0.0008643903],"genre_scores_gemma":[0.9892184,0.002178409,0.002290839,0.001179847,0.0004203718,0.002982405,0.0006920116,0.00002201255,0.001015601],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003590314,"threshold_uncertainty_score":0.01758766,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01058859544530451,"score_gpt":0.2721866867668637,"score_spread":0.2615980913215592,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}